Agilent Technologies, Inc. (A) Issues Q4 Earnings Guidance
Agilent Technologies, Inc. (NYSE:A) updated its fourth quarter earnings guidance on Tuesday. The company provided EPS guidance of $0.60-0.62 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.60. The company issued revenue guidance of $1.15-1.17 billion, compared to the consensus revenue estimate of $1.15 billion.
A has been the topic of several recent research reports. Barclays PLC reissued a buy rating and issued a $67.00 price target on shares of Agilent Technologies in a research note on Wednesday, July 19th. Wells Fargo & Company raised Agilent Technologies from a market perform rating to an outperform rating and lifted their price target for the company from $42.92 to $60.73 in a research note on Wednesday, July 12th. Deutsche Bank AG reissued a buy rating and issued a $66.00 price target on shares of Agilent Technologies in a research note on Thursday, June 22nd. BidaskClub raised Agilent Technologies from a buy rating to a strong-buy rating in a research note on Sunday, August 6th. Finally, Morgan Stanley reissued an overweight rating on shares of Agilent Technologies in a research note on Monday, July 10th. Two research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. Agilent Technologies currently has a consensus rating of Buy and a consensus price target of $60.12.
Agilent Technologies, Inc. (NYSE:A) traded down 0.40% during mid-day trading on Tuesday, hitting $59.38. The company had a trading volume of 2,905,776 shares. The company’s 50 day moving average price is $60.10 and its 200-day moving average price is $55.88. Agilent Technologies, Inc. has a 12-month low of $42.92 and a 12-month high of $61.84. The firm has a market capitalization of $19.08 billion, a PE ratio of 33.38 and a beta of 1.30.
Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Monday, May 22nd. The medical research company reported $0.58 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.48 by $0.10. Agilent Technologies had a net margin of 13.41% and a return on equity of 16.49%. The business had revenue of $1.10 billion for the quarter, compared to analysts’ expectations of $1.05 billion. During the same quarter last year, the firm earned $0.44 EPS. The firm’s revenue for the quarter was up 8.1% compared to the same quarter last year. On average, analysts forecast that Agilent Technologies, Inc. will post $2.23 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Wednesday, July 26th. Investors of record on Monday, July 3rd were given a $0.132 dividend. The ex-dividend date was Thursday, June 29th. This represents a $0.53 annualized dividend and a yield of 0.89%. Agilent Technologies’s payout ratio is 29.78%.
In other Agilent Technologies news, CFO Didier Hirsch sold 5,710 shares of the stock in a transaction dated Thursday, June 1st. The shares were sold at an average price of $60.60, for a total value of $346,026.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Michael R. Mcmullen sold 50,000 shares of the stock in a transaction dated Tuesday, May 23rd. The shares were sold at an average price of $59.86, for a total transaction of $2,993,000.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 112,608 shares of company stock worth $6,737,509.
WARNING: This report was posted by Watch List News and is the property of of Watch List News. If you are viewing this report on another website, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this report can be accessed at https://www.watchlistnews.com/agilent-technologies-inc-a-issues-q4-earnings-guidance/1492168.html.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.